title: Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide.
authors.affiliation: Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Cowan
authors.affiliation: Multicare Regional Cancer Center, Tacoma, WA.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Inoue
authors.affiliation: University of Washington School of Medicine, Seattle Cancer Care Alliance, Seattle, WA. Electronic address: evanyu@u.washington.edu.
authors.forename: Evan Y
authors.initials: EY
authors.lastname: Yu
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage*; D000813:Anilides / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009570:Nitriles / Q000008:administration & dosage*; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013375:Substance Withdrawal Syndrome; D013997:Time Factors; D014105:Tosyl Compounds / Q000008:administration & dosage*
chemical_list: D000726:Androgen Antagonists; D000813:Anilides; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide; D017430:Prostate-Specific Antigen
keywords: Castration-resistant; Clinical trials; Combined androgen blockade; Prostate cancer; Prostate-specific antigen